The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis B
Top Cited Papers
- 1 February 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 34 (2), 306-313
- https://doi.org/10.1016/s0168-8278(00)00094-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Antiviral chemotherapy for the treatment of hepatitis b virus infectionsGastroenterology, 2000
- Long–Term Beneficial Effect of Interferon Therapy in Patients With Chronic Hepatitis B Virus InfectionHepatology, 1999
- Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen‐negative patientsJournal of Viral Hepatitis, 1998
- A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serumHepatology, 1997
- The Treatment of Chronic Viral HepatitisNew England Journal of Medicine, 1997
- Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis BNew England Journal of Medicine, 1996
- Long-term alpha-interferon therapy in anti-HBe positive chronic hepatitis B increases significantly the frequency of sustained responseHepatology, 1994
- Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis BAnnals of Internal Medicine, 1993
- Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type BJournal of Hepatology, 1990
- Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigenHepatology, 1989